Up a level |
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dickson, Rumona ORCID: 0000-0003-1416-0913, Dwan, Kerry, Richardson, Marty ORCID: 0000-0002-7097-8704, Dundar, Yenal, Davis, Helen and Banks, Lindsay
(2015)
Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective.
PHARMACOECONOMICS, 33 (9).
pp. 893-904.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Duarte, Rui, Richardson, Marty ORCID: 0000-0002-7097-8704, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, McEntee, Joanne and Thorp, Nicky
(2019)
Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS-OPEN, 3 (3).
pp. 293-302.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Duarte, Rui, Chaplin, Marty ORCID: 0000-0002-7097-8704, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, Mcentee, Joanne and Thorp, Nicky
(2017)
Eribulin for treating locally advanced or metastatic breast cancer after one prior chemotherapy regimen.
[Report]
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Dwan, Kerry, Beale, Sophie ORCID: 0000-0003-0164-103X, Hockenhull, Juliet ORCID: 0000-0002-2026-3778, Proudlove, Christine, Dundar, Yenal, Richardson, Marty ORCID: 0000-0002-7097-8704, Dickson, Rumona ORCID: 0000-0003-1416-0913 et al (show 2 more authors)
(2015)
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
HEALTH TECHNOLOGY ASSESSMENT, 19 (47).
I-133.
Bagust, Adrian ORCID: 0000-0002-2142-5767 and Beale, Sophie J ORCID: 0000-0003-0164-103X
(2018)
Exploring the Effects of Early Censoring and Analysis of Clinical Trial Survival Data on Effectiveness and Cost-effectiveness Estimation through a Case Study in Advanced Breast Cancer.
MEDICAL DECISION MAKING, 38 (7).
pp. 789-796.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Bagust, Adrian ORCID: 0000-0002-2142-5767, Richardson, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Duarte, Rui et al (show 1 more authors)
(2020)
Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation.
HEALTH TECHNOLOGY ASSESSMENT, 24 (2).
1-+.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Dwan, Kerry, Chaplin, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie, Kotas, Eleanor, Banks, Lindsay and Greystoke, Alastair
(2014)
Nintedanib for previously treated locally advanced or metastatic non small cell lung cancer.
[Report]
Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Bagust, Adrian ORCID: 0000-0002-2142-5767, Richardson, Marty ORCID: 0000-0002-7097-8704, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Duarte, Rui, Kotas, Eleanor, Banks, Lindsay and Palmer, Daniel ORCID: 0000-0002-7147-5703
(2018)
Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PharmacoEconomics, 36 (10).
pp. 1153-1163.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Abdulla, Ahmed, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Richardson, Marty ORCID: 0000-0002-7097-8704, Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, McEntee, Joanne and Palmer, Daniel ORCID: 0000-0002-7147-5703
(2018)
Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS, 36 (3).
pp. 289-299.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Dwan, Kerry, Dickson, Rumona ORCID: 0000-0003-1416-0913, Proudlove, Chris and Dundar, Yenal
(2015)
Pertuzumab in Combination with Trastuzumab and Docetaxel for the Treatment of HER2-Positive Metastatic or Locally Recurrent Unresectable Breast Cancer.
PHARMACOECONOMICS, 33 (1).
pp. 13-23.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Richardson, Marty ORCID: 0000-0002-7097-8704, Krishan, Ashma, Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Abdulla, Ahmed, Kotas, Eleanor, Banks, Lindsay et al (show 1 more authors)
(2017)
Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS, 35 (10).
pp. 1035-1046.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie, Chaplin, Marty ORCID: 0000-0002-7097-8704, Krishan, Ashma, Stainthorpe, Angela, Abdulla, Ahmed, Kotas, Eleanor, Banks, Lindsay et al (show 1 more authors)
(2016)
Talimogene laherparepvec for treating metastatic melanoma.
[Report]